Nan Fung Trinity’s Verona Pharma VRNA Stock Holding History

Nan Fung Trinity’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-76,320	Closed	-$8.14M	–	89
2025 Q3	$8.14M	Sell	76,320 -90,300	-54%	-$9.43M	0.81%	44
2025 Q2	$15.8M	Buy	+166,620	New	+$12.3M	1.89%	25

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Nan Fung Trinity's VRNA Position: Q4 2025 in Review

Nan Fung Trinity sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 76,320 shares — an estimated $8.14M sold.

Nan Fung Trinity first reported a position in VRNA in Q2 2025 and held it in 2 quarters. The position peaked at $15.8M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Nan Fung Trinity reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Nan Fung Trinity sold 76,320 Verona Pharma shares in Q4 2025, an estimated $8.14M.
Nan Fung Trinity first reported a position in Verona Pharma in Q2 2025 and held it in 2 quarters.
Nan Fung Trinity's Verona Pharma position peaked at $15.8M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Nan Fung Trinity's 13F filing for Q4 2025, filed 4 Feb 2026.